1. Sweden Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
XP Chemistries AB

XP Chemistries AB

0.17
SEK
+0.00
(+1.80%)
-0.03EPS
53.22MMarket Cap
Nov 19Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
0.01
0.04
0.02
- -
- -
- -
Basic EPS, GAAP
- -
- -
-0.15
-0.31
-0.25
-0.07
-0.03
-0.03
Free Cash Flow per Basic Share
- -
- -
-0.27
-0.46
-0.36
-0.08
-0.04
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
1.05
0.78
0.27
0.14
0.19
0.1
Tangible Book Value per Share
- -
- -
0.85
0.6
0.18
0.09
0.15
0.08
Basic Weighted Avg Shares
20
20
30
26
32
108
248
285
Sales/Revenue/Turnover
- -
- -
- -
1
1
- -
- -
- -
Operating Margin (%)
- -
- -
-1,875.06
-933.67
-1,522.75
-3,144.34
-3,224.31
-3,716.31
Depreciation Expense
- -
- -
- -
1
1
1
2
2
Net Income, GAAP
- -
- -
-5
-8
-8
-7
-9
-10
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-1,626.81
-749.81
-1,211.26
-2,512.39
-2,602.56
-2,985.82
Working Capital
- -
- -
21
16
9
4
16
10
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
31
29
26
22
37
32
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-29
-26.23
-29.36
-30.19
-29.13
-25.99

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
199
314
314
Market Capitalization
36
58
53

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
18
15
12
Cash, Cash Equivalents & STI
15
12
10
Accounts Receivable, Net
- -
- -
- -
Inventories
2
2
2
Total Current Liabilities
1
2
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
12,507.71%
71.3%
Free Cash Flow
- -
- -
7.61%
Net Income, GAAP
- -
- -
19.44%
Sales/Revenue/Turnover
- -
- -
15.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.02
-0.02
-0.01
-0.07
2025
-0.01
-0.01
-0.01
-0.01
-0.03
2026
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Erik Nelsson
Full Time Employees
1
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Storgatan 73F Sundsvall VN Sweden 852 33
IPO Date
Oct 29, 2021
Website
xpchemistries.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
XP Chemistries AB (publ) XP Chemistries AB (publ) (XPC.ST), a Sweden-based biotechnology company founded in 2018 and headquartered in Sundsvall, develops and produces sustainable, forest-based capsaicin and analogues using patented, eco-friendly catalytic processes from renewable biomass; it offers animal feed ingredients to reduce antibiotic use, personal care and cosmetic ingredients, pure capsaicinoids for life sciences and dietary supplements including the Precise HEAT brand, and self-defense spray ingredients, with operations spanning Europe and North America targeting animal farming, pharmaceuticals, cosmetics, and industrial applications. The company holds a comprehensive international patent portfolio for nature-inspired technologies aimed at UN sustainable development goals, such as green pharmaceutical intermediates and accessible natural flavors. Recent developments include receiving product orders such as SEK 220,000 in value and for Precise HEAT, narrowing operating losses in Q2 and Q3 2025 to SEK 2.1-2.2 million, ensuring full utilization of TO2 subscription options via bonds and guarantees, appointing Anders Frejdh as returning CFO and Patrik Fagerholm previously, insider purchases by CEO Erik Nelsson, and submitting capsaicin information for EFSA animal feed approval, alongside regular interim reports like the January-September 2025 release.